These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1266449)

  • 1. [Antibacterial and antiviral activity of beta,beta-dichlorvinylpyrrolidone].
    Lidina PV; Voronkov MG; Mirskova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Feb; (2):102-5. PubMed ID: 1266449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodological approaches to the study of antiviral substances].
    Noskov FS; Maslennikova LK; Nikitina LE
    Tr Inst Im Pastera; 1979; 52():82-7. PubMed ID: 550550
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral compounds. XII. Antiviral activity of amidinohydrazones of alkoxyphenyl-substituted carbonyl compounds against influenza virus in eggs and in mice.
    Nishimura T; Toku H; Fukuyasu H
    Kitasato Arch Exp Med; 1977 Jun; 50(1-2):39-46. PubMed ID: 616473
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus.
    Meneghesso S; Vanderlinden E; Stevaert A; McGuigan C; Balzarini J; Naesens L
    Antiviral Res; 2012 Apr; 94(1):35-43. PubMed ID: 22306172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor-sensitive and inhibitor-resistant influenza A2 virus populations.
    Barb K; Takátsy G
    Acta Microbiol Acad Sci Hung; 1972; 19(3):195-205. PubMed ID: 4677587
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine.
    Lavrov SV; Eremkina EI; Orlova TG; Galegov GA; Soloviev VD; Zhdanov VM
    Nature; 1968 Mar; 217(5131):856-7. PubMed ID: 5641149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the antiviral action of the newly synthetized compound F-VMI-15 on the reproduction of influenza virus type A2 (Hong Kong) 68 in cell cultures].
    Gagov I; Uzunova A; Georgiev G; Drianovska L
    Izv Mikrobiol Inst (Sofiia); 1972; 23():129-33. PubMed ID: 4663870
    [No Abstract]   [Full Text] [Related]  

  • 8. An Influenza Virus Entry Inhibitor Targets Class II PI3 Kinase and Synergizes with Oseltamivir.
    O'Hanlon R; Leyva-Grado VH; Sourisseau M; Evans MJ; Shaw ML
    ACS Infect Dis; 2019 Oct; 5(10):1779-1793. PubMed ID: 31448902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiviral activity of some related benzo(b)thiophene derivatives. I. Initial screening tests.
    Boyd JE; Sommerville RG
    Arch Gesamte Virusforsch; 1974; 45(3):249-53. PubMed ID: 4370660
    [No Abstract]   [Full Text] [Related]  

  • 10. Herquline A, produced by Penicillium herquei FKI-7215, exhibits anti-influenza virus properties.
    Chiba T; Asami Y; Suga T; Watanabe Y; Nagai T; Momose F; Nonaka K; Iwatsuki M; Yamada H; Ōmura S; Shiomi K
    Biosci Biotechnol Biochem; 2017 Jan; 81(1):59-62. PubMed ID: 26999706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of influenza A2 virus to the non-specific alpha-inhibitor of Francis (the thermoresistance of the sialidase of several variants of influenza A2 virus)].
    Fridman EA; Vishnevskiĭ VG; Sinitskiĭ AA
    Vopr Virusol; 1969; 14(6):691-5. PubMed ID: 5369469
    [No Abstract]   [Full Text] [Related]  

  • 12. [A screening method for anti-influenzal drugs; influenza virus propagation inhibition test (author's transl)].
    Tao SJ
    Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):359-61. PubMed ID: 6796238
    [No Abstract]   [Full Text] [Related]  

  • 13. [New strategy for targeting influenza virus replication].
    Dias A; Bouvier D; Cusack S; Ruigrok RW; Crépin T
    Med Sci (Paris); 2009 Apr; 25(4):352-4. PubMed ID: 19409186
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities.
    Sipos A; Máté G; Rőth E; Borbás A; Batta G; Bereczki I; Kéki S; Jóna I; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Herczegh P
    Eur J Med Chem; 2012 Dec; 58():361-7. PubMed ID: 23149298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of antiviral effect of some herbs on influnza virus reproduction].
    Manolova N; Gagov I; Bakalova D; Nikolov P
    Izv Mikrobiol Inst (Sofiia); 1967; 19():241-5. PubMed ID: 5628765
    [No Abstract]   [Full Text] [Related]  

  • 16. A rapid, simple and reliable method for the screening of potential antiviral compounds in vitro.
    Boyd JE; Sommerville RG
    Arch Gesamte Virusforsch; 1974; 45(3):254-8. PubMed ID: 4371473
    [No Abstract]   [Full Text] [Related]  

  • 17. BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses.
    Shih SR; Horng JT; Poon LL; Chen TC; Yeh JY; Hsieh HP; Tseng SN; Chiang C; Li WL; Chao YS; Hsu JT
    J Antimicrob Chemother; 2010 Jan; 65(1):63-71. PubMed ID: 19892833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-influenza virus activity of novel pyrimidine derivatives.
    Hisaki M; Imabori H; Azuma M; Suzutani T; Iwakura F; Ohta Y; Kawanishi K; Ichigobara Y; Node M; Nishide K; Yoshida I; Ogasawara M
    Antiviral Res; 1999 Jun; 42(2):121-37. PubMed ID: 10389655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the degree and spectrum of antiviral activity of 2-(1'-aminoethyl)-bicyclo[2.2.1]heptane hydrochloride].
    Votiakov VI; Boreko EI; Rusiaev VA; Shashikhina MN; Kazak NF
    Vopr Virusol; 1982; 27(2):172-6. PubMed ID: 7090343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
    Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
    Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.